Decreased Expression of T Lymphocyte Co-Stimulatory Molecule CD26 on Invariant Natural Killer T Cells in Systemic Lupus Erythematosus

REFERENCES

• Ajami K., Pitman M. R., Wilson C. H., Park J., Menz R. I., Starr A. E., Cox J. H., Abbott C. A., Overall C. M., Gorrell M. D. Stromal cell-derived factors 1alpha and 1beta, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8. FEBS Lett. 2008; 582: 819–825
   PubMed Web of Science ®Google Scholar
• Araki M., Kondo T., Gumperz J. E., Brenner M. B., Miyake S., Yamamura T. Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission. Int. Immunol. 2003; 15: 279–288
   PubMed Web of Science ®Google Scholar
• Augustyns K., Bal G., Thonus G., Belyaev A., Zhang X. M., Bollaert W., Lambeir A. M., Durinx C., Goossens F., Haemers A. The unique properties of dipeptidyl-peptidase IV (DPPIV/CD26) and the therapeutic potential of DPPIV inhibitors. Curr. Med. Chem. 1999; 6: 311–327
   PubMed Web of Science ®Google Scholar
• Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392: 565–568
   PubMed Web of Science ®Google Scholar
• Beyan E., Beyan C., Turan M. Hematological presentation in systemic lupus erythematosus and its relationship with disease activity. Hematology 2007; 12: 257–2561
   PubMed Web of Science ®Google Scholar
• Bombardier C., Gladman D. D., Urowitz M. B., Caron D., Chang C. H. the Committee on Prognosis studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum. 1992; 35: 630–640
   PubMed Web of Science ®Google Scholar
• Busso N., Wagtmann C., Herling V., Chobaz-Péclat V., Bischof-Delaloye A., So A., Grouzmann E. Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Am. J. Pathol. 2005; 166: 433–442
   PubMedGoogle Scholar
• Cheng H. C., Abdel-Ghany M., Elble R. C., Pauli B. U. Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin. J. Biol. Chem. 1998; 273: 24207–24215
   PubMed Web of Science ®Google Scholar
• Constantinescu C. S., Kamoun M., Dotti M., Farber R. E., Galetta S. L., Rostami A. A longitudinal study of the T cell activation marker CD26 in chronic progressive multiple sclerosis. J. Neurol. Sci. 1995; 130: 178–182
   Google Scholar
• Green M. R., Kennell A. S., Larche M. J., Seifert M. H., Isenberg D. A., Salaman M. R. Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IgG production. Arthritis Rheum. 2007; 56: 303–310
   Google Scholar
• Gutheil W. G., Subramanyam M., Flentke G. R., Sanford D. G., Munoz E., Huber B. T., Bachovchin W. W. Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity. Proc. Natl. Acad. Sci. USA 1994; 91: 6594–6598
   PubMed Web of Science ®Google Scholar
• Huang L., Cheng H. C., Isom R., Chen C. S., Levine R. A., Pauli B. U. Protein kinase Cepsilon mediates polymeric fibronectin assembly on the surface of blood-borne rat breast cancer cells to promote pulmonary metastasis. J. Biol. Chem. 2008; 283: 7616–7627
   Google Scholar
• Jensen J., Langkilde A. R., Fenst C., Nicolaisen M. S, Roed H. G., Christiansen M., Sellebjerg F. CD4 T cell activation and disease activity at onset of multiple sclerosis. J. Neuroimmunol. 2004; 149: 202–209
   Google Scholar
• Kabashima K., Murata T., Tanaka H., Matsuoka T., Sakata D., Yoshida N., Katagiri K., Kinashi T., Tanaka T., Miyasaka M., Nagai H., Ushikubi F., Narumiya S. Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat. Immunol. 2003; 4: 694–701
   PubMed Web of Science ®Google Scholar
• Kobayashi H., Hosono O., Mimori T., Kawasaki H, Dang N. H., Tanaka H., Morimoto C. Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus. J. Rheumatol. 2002; 29: 1858–1866
   PubMed Web of Science ®Google Scholar
• Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 2005; 23: 877–900
   PubMed Web of Science ®Google Scholar
• Lambeir A., M, Durinx C, Scharpé S., De Meester I. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit. Rev. Clin. Lab. Sci. 2003; 40: 209–294
   PubMed Web of Science ®Google Scholar
• Lit L. C., Wong C. K., Tam L. S., Li E. K., Lam C. W. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 2006; 65: 209–215
   PubMed Web of Science ®Google Scholar
• Lun S. W. M., Wong C. K., Ko F. W. S., Hui D. S. C., Lam C. W. K. Increased expression of plasma and CD4+ T lymphocyte costimulatory molecule CD26 in adult patients with allergic asthma. J. Clin. Immunol. 2007; 27: 430–437
   PubMed Web of Science ®Google Scholar
• McIntosh C. H. Dipeptidyl peptidase IV inhibitors and diabetes therapy. Front. Biosci. 2008; 13: 1753–1773
   PubMed Web of Science ®Google Scholar
• Mercer J. C., Ragin M. J., August A. Natural killer T cells: Rapid responders controlling immunity and disease. Int. J. Biochem. Cell Biol. 2005; 37: 1337–1343
   PubMed Web of Science ®Google Scholar
• Morimoto C., Lord C. I., Zhang C., Duke-Cohan J. S., Letvin N. L., Schlossman S. F. Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis. Proc. Natl. Acad. Sci. USA 1994; 91: 9960–9964
   PubMed Web of Science ®Google Scholar
• Ohtsuki T., Hosono O., Kobayashi H., Munakata Y., Souta A., Shioda T., Morimoto C. Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1α by CD26/dipeptidyl peptidase IV. FEBS Lett. 1998; 431: 236–240
   PubMedGoogle Scholar
• Oshikawa K., Sugiyama Y. Elevated soluble CD26 levels in patients with tuberculous pleurisy. Int. J. Tuberc. Lung Dis. 2001; 9: 868–872
   Google Scholar
• Porcelli S., Yockey C. E., Brenner M. B., Balk S. P. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-CD8- alpha/beta T cells demonstrates preferential use of several Vbeta genes and an invariant TCR alpha chain. J. Exp. Med. 1993; 178: 1–16
   PubMed Web of Science ®Google Scholar
• Preller V., Gerber A, Wrenger S., Togni M., Marguet D., Tadje J., Lendeckel U., Röcken C., Faust J., Neubert K., Schraven B., Martin R., Ansorge S., Brocke S., Reinhold D. TGF-1-Mediated Control of Central Nervous System Inflammation and Autoimmunity through the Inhibitory Receptor CD26. J. Immunol. 2007; 178: 4632–4640
   PubMedGoogle Scholar
• Proost P., Schutyser E., Menten P., Struyf S., Wuyts A., Opdenakker G., Detheux M., Parmentier M., Durinx C., Lambeir A. M., Neyts J., Liekens S., Maudgal P. C., Billiau A., Van Damme J. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 2001; 98: 3554–3561
   PubMed Web of Science ®Google Scholar
• Racke M. K., Dhib-Jalbut S., Cannella B., Albert P. S., Raine C. S., McFarlin D. E. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J. Immunol. 1991; 146: 3012–3017
   PubMed Web of Science ®Google Scholar
• Reinhold D., Kähne T., Steinbrecher A., Wrenger S., Neubert K., Ansorge S., Brocke S. The role of dipeptidyl peptidase IV (DP IV) enzymatic activity in T cell activation and autoimmunity. Biol. Chem. 2002; 383: 1133–1138
   PubMed Web of Science ®Google Scholar
• Sakuishi K., Oki S., Araki M., Porcelli S. A., Miyake S., Yamamura T. Invariant NKT cells biased for IL-5 production act as crucial regulators of inflammation. J. Immunol. 2007; 179: 3452–3462
   PubMed Web of Science ®Google Scholar
• Sen Y., Yongyi B., Yuling H., Luokun X., Li H., Jie X., Tao D., Gang Z., Junyan L., Chunsong H., Zhang X., Youxin J., Feili G., Boquan J., Jinquan T. V alpha 24-invariant NKT cells from patients with allergic asthma express CCR9 at high frequency and induce Th2 bias of CD3+ T cells upon CD226 engagement. J. Immunol. 2005; 175: 4914–4926
   PubMed Web of Science ®Google Scholar
• Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25: 1271–1277
   PubMed Web of Science ®Google Scholar
• Tanaka T., Duke-Cohan J. S., Kameoka J., Yaron A., Lee I., Schlossman S. F., Morimoto C. Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proc. Natl. Acad. Sci. USA 1994; 91: 3082–3086
   PubMed Web of Science ®Google Scholar
• Thompson M. A., Ohnuma K., Abe M., Morimoto C., Dang N. H. CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders. Mini. Rev. Med. Chem. 2007; 7: 253–273
   PubMed Web of Science ®Google Scholar
• Tokano Y., Morimoto S., Kaneko H., Amano H., Nozawa K., Takasaki Y., Hashimoto H. Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)--relation to Th1- and Th2-derived cytokines. Clin. Exp. Immunol. 1999; 116: 169–173
   PubMed Web of Science ®Google Scholar
• Valencia X., Yarboro C., Illei G., Lipsky P. E. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol. 2007; 178: 2579–2588
   PubMed Web of Science ®Google Scholar
• Viallard J. F., Pellegrin J. L., Ranchin V., Schaeverbeke T., Dehais J., Longy-Boursier M., Ragnaud J. M., Leng B., Moreau J. F. Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 1999; 115: 189–195
   PubMed Web of Science ®Google Scholar
• Wong C. K., Ho C. Y., Li E. K., Tam L. S., Lam C. W. K. Elevated production of interleukin-18 is associated with renal disease in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 2002; 130: 345–351
   PubMed Web of Science ®Google Scholar
• Wrenger S., Faust J., Mrestani-Klaus C., Fengler A., Stockel-Maschek A., Lorey S., Kahne T., Brandt W., Neubert K., Ansorge S., Reinhold D. Down-regulation of T cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the thromboxane A2 receptor. J. Biol. Chem. 2000; 275: 22180–22186
   PubMedGoogle Scholar
• Wrenger S., Hoffmann T., Faust J., Mrestani-Klaus C, Brandt W., Neubert K., Kraft M., Olek S., Frank R., Ansorge S., Reinhold D. The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth. J. Biol. Chem. 1997; 272: 30283–30288
   Google Scholar